Skip to main content
Premium Trial:

Request an Annual Quote

GENOME express Closes $11M in Second Financing Round

NEW YORK, Dec. 10 - French genomics-tool company GENOME express has raised 12.4 million euros, or roughly $11 million, in a second round of financing, the company said on Monday.


It said it plans to use the cash to leverage its high throughput DNA sequencing and related products, including DNA libraries, bioinformatics, and data qualification, as well as to discover new therapeutic targets in microbiology and the central nervous system.


"We plan to grow GENOME express in international markets both organically and by acquisition," Yves Laurent, CEO of GENOME express, said in a statement. "Over 2002, we will develop our ability to generate intellectual property, offer high added value to our customers and create mutually beneficial partnerships."

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.